Ethical Accountability Accountability regarding ethical actions been questioned. One example includes the Parliamentary Assembly of the Council of Europe which suggested that WHO’s overreaction may be tied to the relationship with the pharmaceutical industry. Health experts have made strong recommendations for WHO to refrain from competing with other global participants for the resources for treatment programs and resources for vaccinations since they already have influential supporters and experts to provide data. (WHO: About/pharmaceutical).
SWOT.
Strengths. The World Health Organization biggest strength stems from their standard practices utilized in diagnosing and the treatment of diseases. Their collaboration with all of the United …show more content…
WHO was instrumental in eradicating smallpox with their vaccination programs, as well as, continuing success with malaria and other tropical diseases. Polio, HIV/AIDS and Ebola are still on their agenda in their fight to bring wellness to the globe. Weaknesses. WHO has not been able to carry out comprehensive health reforms to meet the agency’s overarching goals due to the fact they are underfinanced. The have reacted to this competition without a clear orientation and have not made the best use of the new players and failed to cooperate with the donors in public-private partnerships. The World Health Organization has overlooked the underlying conflicts, in which private donors are often connected with pharmaceutical firms, who advocate for huge vaccination programs and the use of pharmaceutical drugs. This results in combining the good purpose of helping people with the practice of making money. This has resulted in, the sale of large amounts of vaccines and expensive AIDS drugs being paid for (funded) with limited charity …show more content…
For example: They reacted by hesitating and timidly to the nuclear catastrophes of Chernobyl in 1986 and Fukushima in 2011. WHO failed to send their own experts in time to perform on-site inspections, including radiation measurements, and has even published reports playing down the issues. During the flu pandemic in 2009, WHO exaggerated the risks and requested millions of dollars in funding for vaccine, which resulted in many not being used. The Parliamentary Assembly of the Council of Europe suggested that WHO’s overreaction may be tied to the relationship with the pharmaceutical industry. Health experts have made strong recommendations for WHO to refrain from competing with other global participants for the resources for treatment programs and resources for vaccinations since they already have influential
SWOT.
Strengths. The World Health Organization biggest strength stems from their standard practices utilized in diagnosing and the treatment of diseases. Their collaboration with all of the United …show more content…
WHO was instrumental in eradicating smallpox with their vaccination programs, as well as, continuing success with malaria and other tropical diseases. Polio, HIV/AIDS and Ebola are still on their agenda in their fight to bring wellness to the globe. Weaknesses. WHO has not been able to carry out comprehensive health reforms to meet the agency’s overarching goals due to the fact they are underfinanced. The have reacted to this competition without a clear orientation and have not made the best use of the new players and failed to cooperate with the donors in public-private partnerships. The World Health Organization has overlooked the underlying conflicts, in which private donors are often connected with pharmaceutical firms, who advocate for huge vaccination programs and the use of pharmaceutical drugs. This results in combining the good purpose of helping people with the practice of making money. This has resulted in, the sale of large amounts of vaccines and expensive AIDS drugs being paid for (funded) with limited charity …show more content…
For example: They reacted by hesitating and timidly to the nuclear catastrophes of Chernobyl in 1986 and Fukushima in 2011. WHO failed to send their own experts in time to perform on-site inspections, including radiation measurements, and has even published reports playing down the issues. During the flu pandemic in 2009, WHO exaggerated the risks and requested millions of dollars in funding for vaccine, which resulted in many not being used. The Parliamentary Assembly of the Council of Europe suggested that WHO’s overreaction may be tied to the relationship with the pharmaceutical industry. Health experts have made strong recommendations for WHO to refrain from competing with other global participants for the resources for treatment programs and resources for vaccinations since they already have influential